Abiopharma

🔍 Pollard Randall E. (Executive)

Company: HARROW, INC. (HROW)

Report Date: 2025-09-01

Detailed Transactions and Holdings:

• Acquired 30,000 shares of Stock Option (Right to Buy) at $39.0 per share (Derivative)
  Date: 2025-09-01 | Code: A | Expires: 2035-09-01 | equity_swap_involved: 0 | shares_owned_after: 30,000.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: The shares subject to the option shall vest according to the following schedule: 25% of the shares shall vest at the one-year anniversary of the date of grant, and the remaining shares shall vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on September 1, 2029.